Patented genomics


The patent system is being used to monopolise the all the tools for genomics manipulation.

In the US, for example, it costs a woman between $3,000 and $4,000 to be tested for familial breast cancer that is free in Europe to all women. This is because a corporation owns -in the US only- the patent for the two genes involved.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.